BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 1st Quarter - Report

MACRO BIOLOGICS, INC.

via GRASSROOTS POLITICAL CONSULTING LLC

1st Quarter (Jan 1 - Mar 31) · 2025Posted May 6, 2025Filing document ↗LDA record ↗

Income$10Kfee reported

Client

Name: MACRO BIOLOGICS, INC.
Description: Scientific, biologics developer and manufacturer
Location: California · United States of America

Registrant

Firm: GRASSROOTS POLITICAL CONSULTING LLC
Description: political consulting company
Location: Alexandria, Virginia, United States of America

Lobbying activities

1 issue

Health Issues
Development of Amicidins to serve as a countermeasure/therapeutic intervention for Sepsis
LobbyistsDANIEL FARACI
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

MACRO BIOLOGICS, INC. — Lobbying — Receipts Report